Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19280 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von E Fardella und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Associazione Italiana Contro le Leucemie - Linfomi e Mieloma.
Abstract (Originalsprache)
Peripheral T‐cell lymphomas (PTCLs) have a poor prognosis and, to date, there are no reliable predictive biomarkers of response. In this work we explored the prognostic impact of cell‐free DNA (cfDNA) concentration in 75 newly diagnosed patients enrolled in a prospective multicenter study. Pre‐treatment cfDNA was strongly associated with clinical risk factors and was identified as a superior predictor for shorter progression‐free survival in multivariable analysis, outweighing canonical risk parameters. Furthermore, we identified a cfDNA value above which survival worsens. In conclusion, pre‐treatment cfDNA concentration represents an easily usable predictive biomarker that is highly associated with survival of PTCL patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Milan, Milan, Italy.
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
- Division of Hematology, Azienda Ospedaliera e Universitaria Città della Salute e della Scienza, Turin, Italy.
- Hematology Division, ASST Spedali Civili di Brescia, Brescia, Italy.
- Hematology Unit, Ospedale Oncologico Armando Businco, Cagliari, Italy.
ORCID-Profile: E Fardella, A Chiappella, A Pinto, C Carniti, P Corradini
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Associazione Italiana Contro le Leucemie - Linfomi e Mieloma
Zitieren
APA
Fardella, E., Zanirato, G., Magni, M., Caldarelli, N., Chiappella, A., Dodero, A., Ljevar, S., Orsucci, L., Re, A., Usai, S. V., Stefoni, V., Castellino, C., Rossi, F. G., Pinto, A., Carniti, C., & Corradini, P. (2024). Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas. British Journal of Haematology. https://doi.org/10.1111/bjh.19280
Vancouver
Fardella E, Zanirato G, Magni M, Caldarelli N, Chiappella A, Dodero A, et al. Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas. British Journal of Haematology. 2024. doi:10.1111/bjh.19280
BibTeX
@article{Fardella2024,
author = {Fardella, E and Zanirato, G and Magni, M and Caldarelli, N and Chiappella, A and Dodero, A and Ljevar, S and Orsucci, L and Re, A and Usai, S V and Stefoni, V and Castellino, C and Rossi, F G and Pinto, A and Carniti, C and Corradini, P},
title = {Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19280}
}
EUVIMED